Guardant Health Statistics
Total Valuation
Guardant Health has a market cap or net worth of $5.83 billion. The enterprise value is $6.24 billion.
Important Dates
The next confirmed earnings date is Thursday, February 20, 2025, after market close.
| Earnings Date | Feb 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Guardant Health has 123.55 million shares outstanding. The number of shares has increased by 12.48% in one year.
| Current Share Class | 123.55M |
| Shares Outstanding | 123.55M |
| Shares Change (YoY) | +12.48% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 4.27% |
| Owned by Institutions (%) | 90.91% |
| Float | 104.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.28 |
| Forward PS | 7.03 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.22
| Current Ratio | 6.22 |
| Quick Ratio | 5.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -166.26 |
Financial Efficiency
Return on equity (ROE) is -609.28% and return on invested capital (ROIC) is -18.72%.
| Return on Equity (ROE) | -609.28% |
| Return on Assets (ROA) | -16.08% |
| Return on Invested Capital (ROIC) | -18.72% |
| Return on Capital Employed (ROCE) | -31.99% |
| Revenue Per Employee | $389,126 |
| Profits Per Employee | -$288,033 |
| Employee Count | 1,779 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 3.68 |
Taxes
In the past 12 months, Guardant Health has paid $27,000 in taxes.
| Income Tax | 27,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +112.57% in the last 52 weeks. The beta is 1.33, so Guardant Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | +112.57% |
| 50-Day Moving Average | 37.34 |
| 200-Day Moving Average | 28.79 |
| Relative Strength Index (RSI) | 66.04 |
| Average Volume (20 Days) | 2,586,905 |
Short Selling Information
The latest short interest is 7.36 million, so 5.96% of the outstanding shares have been sold short.
| Short Interest | 7.36M |
| Short Previous Month | 7.79M |
| Short % of Shares Out | 5.96% |
| Short % of Float | 7.03% |
| Short Ratio (days to cover) | 3.86 |
Income Statement
In the last 12 months, Guardant Health had revenue of $692.26 million and -$512.41 million in losses. Loss per share was -$4.22.
| Revenue | 692.26M |
| Gross Profit | 417.53M |
| Operating Income | -429.11M |
| Pretax Income | -490.27M |
| Net Income | -512.41M |
| EBITDA | -386.31M |
| EBIT | -429.11M |
| Loss Per Share | -$4.22 |
Full Income StatementBalance Sheet
The company has $927.00 million in cash and $1.34 billion in debt, giving a net cash position of -$412.41 million or -$3.34 per share.
| Cash & Cash Equivalents | 927.00M |
| Total Debt | 1.34B |
| Net Cash | -412.41M |
| Net Cash Per Share | -$3.34 |
| Equity (Book Value) | -60.10M |
| Book Value Per Share | -0.49 |
| Working Capital | 1.03B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$254.07 million and capital expenditures -$20.29 million, giving a free cash flow of -$274.36 million.
| Operating Cash Flow | -254.07M |
| Capital Expenditures | -20.29M |
| Free Cash Flow | -274.36M |
| FCF Per Share | -$2.22 |
Full Cash Flow StatementMargins
Gross margin is 60.31%, with operating and profit margins of -61.99% and -74.02%.
| Gross Margin | 60.31% |
| Operating Margin | -61.99% |
| Pretax Margin | -74.02% |
| Profit Margin | -74.02% |
| EBITDA Margin | -55.80% |
| EBIT Margin | -61.99% |
| FCF Margin | n/a |
Dividends & Yields
Guardant Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.48% |
| Shareholder Yield | -12.48% |
| Earnings Yield | -8.79% |
| FCF Yield | -4.71% |
Dividend DetailsAnalyst Forecast
The average price target for Guardant Health is $42.57, which is -9.75% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $42.57 |
| Price Target Difference | -9.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 23.62% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Guardant Health has an Altman Z-Score of -0.78 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.78 |
| Piotroski F-Score | 3 |